Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Mid-term results of endovascular treatment of abdominal aortic aneurysm in kidney transplant recipients

J Szmidt, Z Gałązka, O Rowiński, T Jakimowicz, M Durlik, Ł Romanowski, B Solonynko

Ann Transplant 2009; 14(1): 47-47 :: ID: 880369

Abstract

Background: The number of abdominal aortic aneurysms (AAA) in kidney
transplant recipients is increasing. Previously performed open aneurysmectomy is technically difficult and burdened with high risk of ischemic injury to transplanted kidney. The aim of the study was to assess the results of endovascular AAA treatment in kidney transplant recipients.
Material/Methods: Since 1998 endovascular treatment of AAA was performed in 665 patients in our Department. Eleven (1.65%) were kidney transplant recipients. Time between kidney transplantation and AAA management was 3 to 19 years. In 7 patients' graft's renal artery was anastomosed by end-to-end method to hypogastric artery, in remaining patients' end-to-side to external iliac artery. Bifurcated stent-grafts were implanted under epidural anaesthesia. All patients were followed-up with Doppler ultrasound or CT-scan performed according to Eurostar protocol. Kidney function was assessed two to four times a year.
Results: Successful AAA exclusion and preserved flow to transplanted kidney were confirmed on the final angiogram in all patients. Temporary deterioration of transplanted kidney function was observed in three patients, one of them required transient haemodialysis. In follow-up there was one stent-graft's limb thrombosis at 9 months after stent-graft's implantation that required femoro-femoral by-pass. In two patients there was endoleak type I treated successfully with proximal extension. The mean observation period was 34 months (range 3-80 months).
Conclusions: Endovascular treatment of AAA in kidney transplant recipients can be performed without major complications and serious deterioration of graft function. Thus this is a safe and effective method and can be considered as a treatment of choice.

Keywords: Kidney Transplantation

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358